Analyse Amexdrug Corporation (AXRX) — Kairos Score 56/100

À propos de Amexdrug Corporation

Amexdrug Corporation, through its subsidiaries, engages in the research, development, manufacturing, and distribution of pharmaceutical drugs in the United States. The company operates in two segments, Distribution, and Health and Beauty Products. It offers brand and generic pharmaceuticals, prescription and over-the-counter drugs, non-drug products, health and beauty products, nutritional supplements, as well as pharmacy and laboratory supplies under the Sponix brand name. The company is also involved in private manufacturing and labeling activities. It sells its products through traditional wholesale distribution lines, e-commerce venues, and owned website to independent pharmacies, secondarily to small-sized pharmacy chains, and alternative care facilities, as well as wholesalers and retailers. The company was formerly known as Harlyn Products, Inc. and changed its name to Amexdrug Corporation in April 2000. Amexdrug Corporation was incorporated in 1963 and is based in Commerce, California.

Informations clés

🕴️ Activité des initiés (90 jours)

0 transactions — 0 achats et 0 ventes déclarés par les dirigeants de Amexdrug Corporation.

🏦 Hedge Funds

0 fonds institutionnels déclarent une position sur AXRX dans leur dernière déclaration trimestrielle SEC.

🧠 Ce qui fait Kairos Insider

Au-dela des donnees brutes, nous agregeons et scoring tout le signal smart money pour vous donner une vue unique.